Philippe Martel,Itaru Suzuki,Johannes Voegel,Philippe Andres,Sandrine Rethore
申请号：
US14365851
公开号：
US20140371147A1
申请日:
2012.12.17
申请国别(地区):
US
年份:
2014
代理人:
摘要：
A combination of compounds is described for the treatment and/or prevention of skin conditions linked to hypopigmentation. Also described, is a combination product that includes at least one prostaglandin receptor agonist and at least one MC1R receptor agonist, as a medicament for use simultaneously, separately or spread out over time for the treatment and/or prevention of skin conditions linked to hypopigmentation, such as vitiligo.
